U.S. Markets closed
  • S&P Futures

    3,451.25
    +2.00 (+0.06%)
     
  • Dow Futures

    28,281.00
    +13.00 (+0.05%)
     
  • Nasdaq Futures

    11,666.50
    +16.75 (+0.14%)
     
  • Russell 2000 Futures

    1,632.10
    +1.50 (+0.09%)
     
  • Crude Oil

    40.64
    0.00 (0.00%)
     
  • Gold

    1,907.20
    +2.60 (+0.14%)
     
  • Silver

    24.73
    +0.02 (+0.06%)
     
  • EUR/USD

    1.1802
    -0.0024 (-0.2006%)
     
  • 10-Yr Bond

    0.8480
    +0.0320 (+3.92%)
     
  • Vix

    28.11
    -0.54 (-1.88%)
     
  • GBP/USD

    1.3068
    -0.0012 (-0.0941%)
     
  • USD/JPY

    104.7240
    -0.1160 (-0.1106%)
     
  • BTC-USD

    12,956.20
    +51.22 (+0.40%)
     
  • CMC Crypto 200

    261.14
    +5.04 (+1.97%)
     
  • FTSE 100

    5,785.65
    +9.15 (+0.16%)
     
  • Nikkei 225

    23,575.17
    +100.90 (+0.43%)
     

Stocks - Moderna, Apple Rise Premarket; Hasbro Falls

·2 mins read

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Monday, July 27th. Please refresh for updates.

Moderna (NASDAQ:MRNA) stock rose 8.2% after the drugmaker said Sunday it has received an additional $472 million from the U.S. government to support the development of its novel coronavirus vaccine. It also received $483 million in April.

Hasbro (NASDAQ:HAS) stock fell 3.2% after the toymaker reported a net loss of $33.9 million in the second quarter, with revenues down 29%. The company cited “temporary store closures, product shortages in fast-growing categories and lower retail inventory" due to the pandemic.

Apple (NASDAQ:AAPL) stock rose 1.2% despite being removed from JPMorgan’s Focus List. The investment bank keeps its overweight rating, but says "investors looking for further upside have to focus on the longer-term earnings trajectory rather than expect near-term upside." That said, the bank expects an earnings beat when Apple reports this week.

Biogen (NASDAQ:BIIB) stock rose 2.6% after Morgan Stanley (NYSE:MS) upgraded its investment stance on the drugmaker to ‘overweight’ from ‘underweight’, citing prospects for the success of its Alzheimer’s drug aducanumab.

Pacific Gas&Electric (NYSE:PCG) stock rose 0.4% after a Barron’s report suggested that the utility looks undervalued after coming out of bankruptcy protection.

Bloomin Brands (NASDAQ:BLMN) stock rose 3.6% after investment bank JPMorgan (NYSE:JPM) upgraded its stance on the restaurant holding company to ‘overweight’, seeing the company as “a survivor in the space.”

AstraZeneca (NYSE:AZN) ADRs rose 0.5% after the U.K.-based pharma giant agreed to pay up to $6 billion to Japanese drugmaker Daiichi Sankyo, in the second multibillion cancer drug collaboration in a year between the two companies.

Avery Dennison (NYSE:AVY)stock rose 1.3% after reporting a second-quarter earnings beat despite organic sales falling 13.7%.

Related Articles

Futures firm with focus on Fed, earnings rush

Under Armour executives receive Wells notice from SEC

SAP picked by Moderna to help distribute COVID-19 vaccine candidate